If someone you love seems to have gone from “having a few drinks” to full-blown addiction faster than you ever could have imagined, you are not alone — and you are not imagining it. For women in particular, the journey from first use to dependence can be startlingly quick. Researchers have a name for this phenomenon: the telescoping effect.
Understanding the telescoping effect helps families recognize warning signs sooner, helps clinicians provide more effective care, and helps women feel less shame about how quickly their relationship with substances escalated. Below is a detailed look at what the telescoping effect is, why it happens, which substances are most involved, and how compassionate, gender-informed treatment can help.
What Is the Telescoping Effect?
The telescoping effect — also called telescoping bias in the research literature — refers to the accelerated progression from first substance use to dependence and treatment. Think of a telescope collapsing inward: what normally takes years for one person can happen in a fraction of that time for another. When substances telescope, the landmark events of substance use disorder (SUD) — first use, problem use, dependence, and seeking treatment — are compressed into a much shorter window.
Most people diagnosed with a substance use disorder move through a recognizable series of stages before reaching dependence. According to a 2017 study by researchers at the University of Michigan, those stages are:
1 Acquisition (First Use)
2 Escalation (Increased Use)
3 Maintenance (Stabilized Dependence)
4 Withdrawal (Physical Symptoms)
5 Relapse (Return to Use)
When telescoping occurs, the individual races from Acquisition to Escalation and Maintenance much faster than average — and may stabilize at higher doses than someone whose addiction developed more gradually.
Key Statistic: Research published by the Medical University of South Carolina found that it takes men nearly double the time to progress from first intoxication to alcohol addiction compared to women — 2.3 years versus 0.9 years.
Examples of the Telescoping Effect
The telescoping effect shows up across a wide range of real-world situations and substances. Some of the clearest examples come from clinical data and — more relatable to many families — from the public stories of well-known women who struggled with rapid addiction onset.
Clinical Examples of Telescoping
- Alcohol: A woman may begin drinking socially and reach a point of daily dependence within months, while a male peer with the same social pattern takes several years to reach the same level of disorder.
- Opioids: A woman prescribed opioid pain relievers after surgery may develop a physical dependence far more quickly than her male counterparts on the same medication. Research confirms women progress from opioid use to opioid use disorder in a compressed timeline compared to men.
- Cannabis: Studies show women who use cannabis progress to cannabis use disorder in a shorter period than men, even when starting at equivalent amounts.
- Stimulants (methamphetamine, cocaine): Women tend to have stronger cravings and more intense reward responses to stimulants, driving faster escalation of use.
Famous People Who Experienced the Telescoping Effect
While we cannot know every detail of any individual’s addiction history, several high-profile women have publicly described addiction trajectories that align with what researchers describe as telescoping:
- Betty Ford — The former First Lady’s public acknowledgment of her rapid descent into alcohol and prescription drug dependence helped break the stigma around women and addiction, and inspired countless others to seek treatment.
- Demi Lovato — Has spoken openly about how quickly her relationship with alcohol and other substances escalated, noting that what began as occasional use took hold faster than expected and required multiple rounds of intensive treatment.
- Jamie Lee Curtis — The actress has described becoming physically dependent on prescription opioids after a cosmetic procedure in a remarkably short time, eventually requiring treatment and becoming an outspoken advocate for opioid policy reform.
- Drew Barrymore — Entered rehabilitation for the first time at age 13, illustrating how early onset of use (another known factor in telescoping) can accelerate the path to dependence.
These stories underscore that addiction — and particularly its accelerated form — does not discriminate by fame, wealth, or circumstances.
Why Does Telescoping Happen? Hypotheses Researchers Have Formed
Researchers have proposed several overlapping explanations for why some individuals — particularly women — experience the telescoping effect. Most experts believe it is a combination of biological, psychological, and social factors rather than any single cause.
Biological Differences: Body Composition and Pharmacokinetics
Women and men process substances differently at a physiological level. Women generally have a higher percentage of body fat and lower total body water than men of comparable weight. Since many drugs and alcohol are water-soluble, the same dose produces a higher blood concentration in women. Blood alcohol concentration (BAC) rises faster and stays elevated longer in women than in men after equivalent amounts of alcohol. Researchers believe these pharmacokinetic differences, how the body interacts with drugs, help explain why women can develop serious health consequences — including liver damage — sooner and with lower lifetime consumption than men.
Hormonal Influences: Estrogen and the Dopamine Reward Pathway
A growing body of research points to the role of estrogen in amplifying the brain’s reward response. Estrogen is now understood to modulate dopamine signaling in the mesolimbic, the dopamine releasing area of the brain, pathway — the brain’s core reward circuit. Higher estrogen levels have been associated with greater dopamine release and enhanced reward prediction signals, which may make substances feel more reinforcing for women during certain phases of the menstrual cycle. The follicular phase, in particular, is associated with heightened responsivity to stimulants. This biological amplification of reward may accelerate the process of psychological dependence. Preclinical studies have found that female animals develop addiction-like features — including compulsive drug-seeking, enhanced motivation, and greater craving — more readily than male animals.
Co-Occurring Mental Health Disorders
Women experience mental health conditions such as anxiety, depression, and PTSD at higher rates than men. Research suggests women are approximately 75% more likely to report episodes of depression and 60% more likely to report anxiety disorders than men. Because co-occurring disorders are strongly linked to addiction vulnerability, women who turn to substances to manage emotional pain or trauma symptoms may find dependence setting in more quickly. Eating disorders are another significant co-occurring factor: lifetime eating disorder behaviors have been found to co-occur with substance use disorder in up to 40% of women.
Social and Situational Factors
Women face unique social barriers that can delay treatment-seeking even when addiction has already taken root. Caregiving responsibilities, concerns about child custody, stigma, financial dependency, and lack of access to childcare during treatment hours all contribute to women staying in active addiction longer before reaching out for help. By the time many women arrive in treatment, their dependence has become more severe — an outcome that reflects not only biological telescoping but also the social forces that delay intervention.
Historical Research Bias
Until the early 1990s, most addiction research was conducted predominantly on male subjects. The frameworks used to understand and diagnose substance use disorder were built on a “masculine” model of addiction that did not fully account for women’s distinct experiences. This has meant that clinical tools, treatment protocols, and screening criteria were not calibrated for women — potentially causing telescoping in women to go unrecognized and untreated for longer.
Does the Telescoping Effect Occur More in Women or Men?
The weight of current research strongly indicates that the telescoping effect is more pronounced in women than men, particularly for alcohol, opioids, and cannabis. Several key findings bear this out:
- Women initiate alcohol use later than men on average, yet progress to dependence faster — and once dependent, they seek treatment sooner.
- Women who enter addiction treatment programs typically present with more severe physical, psychological, and social difficulties than men, even when they have used substances for a shorter time and in smaller amounts.
- Studies on cannabis use disorder show female users escalating to disorder status in compressed time-frames relative to male users with comparable patterns of use.
- For opioids — including heroin and prescription pain relievers — research confirms that women progress from first use to disorder criteria more rapidly than men.Does Telescoping Happen More in Children Than Adults?
Important nuance: Not every study finds telescoping in every population. Some research on general (non-treatment-seeking) populations has found weaker evidence for a telescoping effect, and there is ongoing debate about which substances and which demographic groups are most affected. The consensus, however, is that gender-informed clinical attention is warranted for women with any substance use concerns.
Does Telescoping Happen More in Children Than Adults?
Age of first use is one of the most powerful predictors of addiction severity. Adolescents and young adults who begin using substances before the brain is fully developed (the brain continues maturing until approximately age 25) are at significantly elevated risk for rapid escalation. Early onset of use interacts with the telescoping effect in important ways:
- The adolescent brain’s reward system is more sensitive and more easily conditioned by substance use, meaning the neurological “grooves” of addiction form faster.
- Young people, especially girls and young women, who have experienced trauma, adverse childhood experiences (ACEs), or early mental health symptoms are particularly vulnerable.
- A young woman who begins drinking or using drugs in early adolescence may reach a point of clinical dependence years earlier than an adult who begins use later in life.
This does not mean that the telescoping effect is exclusively a childhood or adolescent phenomenon — it occurs across age groups. However, the combination of a developing brain and the biological and hormonal factors outlined above creates a particularly high-risk window for rapid addiction onset in young women.
What Substances Are Most Likely to Cause the Telescoping Effect?
Research on the telescoping effect has been most extensive for three substance categories, though evidence is expanding to include others:
Alcohol
Alcohol is the most studied substance in the context of telescoping. The telescoping phenomenon was first observed and documented in relation to alcohol use disorder and remains the most replicated finding. Women develop alcohol-related liver disease, heart damage, and cognitive impairment after lower levels of consumption and over shorter periods than men.
Opioids (Including Heroin and Prescription Pain Medications)
Opioid use disorder shows clear telescoping patterns in women. Women become addicted to heroin and use it at a more accelerated pace than men. The fentanyl crisis has brought additional urgency to this finding, as researchers note that fentanyl has distinct pharmacodynamics that may amplify sex-based differences in opioid vulnerability.
Cannabis
As cannabis use has become more socially accepted and more potent strains have entered the market, the telescoping effect in cannabis use disorder has attracted greater research attention. Women who use cannabis progress from first use to problematic use in a shorter timeframe than male users.
Stimulants (Methamphetamine and Cocaine)
Women tend to be more vulnerable to the reinforcing reward effects of methamphetamine and cocaine. They experience stronger cravings and more intense withdrawal during recovery, which can compress the path from recreational use to compulsive dependence.
Nicotine and Other Substances
Telescoping has also been observed with tobacco and nicotine, with estrogen hypothesized to prime the reward pathway and accelerate the development of nicotine use disorder in women. The telescoping effect has even been documented in non-pharmacological addictions such as gambling, suggesting it reflects a broader neurobiological vulnerability rather than a substance-specific one.
How to Treat Someone Who Has the Telescoping Effect
The good news is that knowing a woman may have experienced telescoping — arriving at treatment with a more severe clinical profile than her history might suggest — allows treatment teams to tailor care more effectively. Here is what evidence-informed, gender-sensitive treatment for telescoping looks like:
Gender-Specific Residential Treatment
Women’s residential treatment programs create an environment where women can address the distinct biological, psychological, and social dimensions of their addiction without the dynamics that often arise in mixed-gender settings. Research consistently shows that gender-specific programs improve engagement and outcomes for women.
Dual Diagnosis Treatment for Co-Occurring Disorders
Because women with the telescoping effect frequently arrive in treatment with elevated rates of depression, anxiety, PTSD, and other co-occurring conditions, integrated dual diagnosis treatment is essential. Treating the addiction in isolation while leaving underlying mental health conditions unaddressed dramatically increases the risk of relapse. A comprehensive assessment on intake should guide a treatment plan that addresses both substance use and any co-occurring disorders simultaneously.
Trauma-Informed Care
A significant proportion of women in addiction treatment have histories of trauma, including domestic violence, sexual assault, or childhood abuse. Trauma-informed approaches — including trauma-focused therapy modalities — recognize the relationship between unresolved trauma and accelerated addiction and provide healing that addresses the root causes of substance use.
Medication-Assisted Treatment (MAT)
For women with opioid or alcohol use disorder, FDA-approved medications such as buprenorphine, naltrexone, or acamprosate can reduce cravings, manage withdrawal, and support long-term recovery. MAT is most effective when combined with counseling and behavioral therapies.
Individualized Therapy and Peer Support
Individual therapy — including cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and motivational interviewing — helps women understand and change the thought patterns and behaviors underlying their substance use. Group therapy with female peers provides connection, accountability, and the shared understanding that recovery is possible regardless of how quickly addiction took hold.
Family and Aftercare Planning
Recovery does not end at discharge. Robust aftercare planning that includes family education, community support groups, and continued outpatient care helps women maintain the gains made in residential treatment and navigate the social and relational challenges that can trigger relapse.
